Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 known ✓ | P27487 | 20/20 | 0.89 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.89 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.87 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Acid SCHEMBL5457701 | 1.00 | DPP4 (0.89) | DPP4DPP8DPP9 | |
| Fumaric Acid SCHEMBL5455492 | 1.00 | DPP4 (0.89) | DPP4DPP8DPP9 | |
| Fumaric Acid SCHEMBL5457707 | 1.00 | DPP4 (0.89) | DPP4DPP8DPP9 | |
| SCHEMBL5449314 | 0.94 | DPP4 (1.00) | DPP4DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL5461517 | 0.93 | DPP4 (1.00) | DPP4DPP8DPP9 | |
| Isopropyl Alcohol SCHEMBL5450455 | 0.91 | DPP4 (0.95) | DPP4DPP8DPP9 | |
| Tert-Butylamine SCHEMBL5456190 | 0.90 | DPP4 (0.91) | DPP4DPP8DPP9 | |
| SCHEMBL5461368 | 0.86 | DPP4 (0.84) | DPP4DPP8DPP9 | |
| SCHEMBL5451985 | 0.86 | DPP4 (0.84) | DPP4DPP8DPP9 | |
| Hydrochloric Acid SCHEMBL5446049 | 0.85 | DPP4 (0.85) | DPP4DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070259927-A1 | Remedy for Diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2007-11-08 | — | — | US | disclosed |
| EP-1782832-A1 | REMEDY FOR DIABETES | Takeda Pharmaceutical Company Limited (JP) | 2007-05-09 | — | — | EP | disclosed |
| US-20070037807-A1 | Pyridine compounds as inhibitors of dipeptidyl peptidase IV | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259927-A1 | Remedy for Diabetes | IAPP, DPP4, PNLIP | DPP4 2/4885DPP8 8/4885DPP9 10/4885 |
| US-20070037807-A1 | Pyridine compounds as inhibitors of dipeptidyl peptidase IV | DPP4, DPP3, PEPD | DPP4 1/4885DPP8 8/4885DPP9 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.